Loading…
Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells
Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups...
Saved in:
Published in: | Molecular and cellular endocrinology 2024-10, Vol.592, p.112296, Article 112296 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3 |
container_end_page | |
container_issue | |
container_start_page | 112296 |
container_title | Molecular and cellular endocrinology |
container_volume | 592 |
creator | Silveira, Henrique Spaulonci Cesário, Roberta Carvalho Vígaro, Renan Aparecido Gaiotte, Leticia Barbosa Cucielo, Maira Smaniotto Guimarães, Fernando Seiva, Fábio Rodrigues Ferreira Zuccari, Debora Aparecida P.C. Reiter, Russel J. Chuffa, Luiz Gustavo de Almeida |
description | Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups, in the presence or absence of the antagonist luzindole. There was a decrease in the levels of HIF-1α, G6PDH, GAPDH, PDH, and CS after Mel treatment even in the presence of luzindole in both OC cells. Mel treatment also reduced the activity of OC-related enzymes including PFK-1, G6PDH, LDH, CS, and GS whereas PDH activity was increased. Lactate and glutamine levels dropped after Mel treatment. Mel further promoted a reduction in the concentrations of CREB, JNK, NF-kB, p-38, ERK1/2, AKT, P70S6K, and STAT in both cell lines. Mel reverses Warburg-type metabolism and possibly reduces glutaminolysis, thereby attenuating various oncogenic molecules associated with OC progression and invasion.
[Display omitted]
•Melatonin reduces glycolysis and increases pyruvate dehydrogenase activity in OC cells.•Ovarian cancer metabolism-related enzyme activities were altered by melatonin.•Melatonin has a broad impact on reducing key molecules associated with OC progression.•Melatonin reverses Warburg-type metabolism of OC cells in the presence of luzindole. |
doi_str_mv | 10.1016/j.mce.2024.112296 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3065980883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0303720724001527</els_id><sourcerecordid>3065980883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3</originalsourceid><addsrcrecordid>eNp9kLFu2zAQhokiQe2kfYAugcYsco-kRFLoVARpUyBFl2TKQFDkSaUhkQ4pB_Dbl4bTjJluuO__cfcR8oXChgIVX7eb2eKGAWs2lDLWiQ9kTZVktYJWnpE1cOC1ZCBX5CLnLQDIlqmPZMWVahroxJo8_cbJLDH4UNm_JoyYKwyYxkM142L6OPk8Vya4KqHb27KNwcYRg7dV9mMwkw9jVcLxxSRvSokJFlNlcZryJ3I-mCnj59d5SR5_3D7c3NX3f37-uvl-X1vG26XmxjaqAacYH5zgvRFcUWpt6wCMEj0g9EK2CriT_TAIyXvWSVQCGmmHfuCX5PrUu0vxeY950bPPxwtMwLjPmoNoOwVK8YLSE2pTzDnhoHfJzyYdNAV9dKq3ujjVR6f65LRkrl7r9_2M7i3xX2IBvp0ALE--eEw6W4_Fg_MJ7aJd9O_U_wPm_Ieb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3065980883</pqid></control><display><type>article</type><title>Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells</title><source>ScienceDirect Journals</source><creator>Silveira, Henrique Spaulonci ; Cesário, Roberta Carvalho ; Vígaro, Renan Aparecido ; Gaiotte, Leticia Barbosa ; Cucielo, Maira Smaniotto ; Guimarães, Fernando ; Seiva, Fábio Rodrigues Ferreira ; Zuccari, Debora Aparecida P.C. ; Reiter, Russel J. ; Chuffa, Luiz Gustavo de Almeida</creator><creatorcontrib>Silveira, Henrique Spaulonci ; Cesário, Roberta Carvalho ; Vígaro, Renan Aparecido ; Gaiotte, Leticia Barbosa ; Cucielo, Maira Smaniotto ; Guimarães, Fernando ; Seiva, Fábio Rodrigues Ferreira ; Zuccari, Debora Aparecida P.C. ; Reiter, Russel J. ; Chuffa, Luiz Gustavo de Almeida</creatorcontrib><description>Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups, in the presence or absence of the antagonist luzindole. There was a decrease in the levels of HIF-1α, G6PDH, GAPDH, PDH, and CS after Mel treatment even in the presence of luzindole in both OC cells. Mel treatment also reduced the activity of OC-related enzymes including PFK-1, G6PDH, LDH, CS, and GS whereas PDH activity was increased. Lactate and glutamine levels dropped after Mel treatment. Mel further promoted a reduction in the concentrations of CREB, JNK, NF-kB, p-38, ERK1/2, AKT, P70S6K, and STAT in both cell lines. Mel reverses Warburg-type metabolism and possibly reduces glutaminolysis, thereby attenuating various oncogenic molecules associated with OC progression and invasion.
[Display omitted]
•Melatonin reduces glycolysis and increases pyruvate dehydrogenase activity in OC cells.•Ovarian cancer metabolism-related enzyme activities were altered by melatonin.•Melatonin has a broad impact on reducing key molecules associated with OC progression.•Melatonin reverses Warburg-type metabolism of OC cells in the presence of luzindole.</description><identifier>ISSN: 0303-7207</identifier><identifier>ISSN: 1872-8057</identifier><identifier>EISSN: 1872-8057</identifier><identifier>DOI: 10.1016/j.mce.2024.112296</identifier><identifier>PMID: 38844096</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Cellular metabolism ; Glutaminolysis ; Kinase signaling ; Melatonin ; Ovarian cancer ; Tumor progression ; Warburg effect</subject><ispartof>Molecular and cellular endocrinology, 2024-10, Vol.592, p.112296, Article 112296</ispartof><rights>2024 Elsevier B.V.</rights><rights>Copyright © 2024. Published by Elsevier B.V.</rights><rights>Copyright © 2024 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3</cites><orcidid>0000-0002-7461-8773 ; 0000-0002-0199-3396 ; 0000-0002-5537-972X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38844096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silveira, Henrique Spaulonci</creatorcontrib><creatorcontrib>Cesário, Roberta Carvalho</creatorcontrib><creatorcontrib>Vígaro, Renan Aparecido</creatorcontrib><creatorcontrib>Gaiotte, Leticia Barbosa</creatorcontrib><creatorcontrib>Cucielo, Maira Smaniotto</creatorcontrib><creatorcontrib>Guimarães, Fernando</creatorcontrib><creatorcontrib>Seiva, Fábio Rodrigues Ferreira</creatorcontrib><creatorcontrib>Zuccari, Debora Aparecida P.C.</creatorcontrib><creatorcontrib>Reiter, Russel J.</creatorcontrib><creatorcontrib>Chuffa, Luiz Gustavo de Almeida</creatorcontrib><title>Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells</title><title>Molecular and cellular endocrinology</title><addtitle>Mol Cell Endocrinol</addtitle><description>Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups, in the presence or absence of the antagonist luzindole. There was a decrease in the levels of HIF-1α, G6PDH, GAPDH, PDH, and CS after Mel treatment even in the presence of luzindole in both OC cells. Mel treatment also reduced the activity of OC-related enzymes including PFK-1, G6PDH, LDH, CS, and GS whereas PDH activity was increased. Lactate and glutamine levels dropped after Mel treatment. Mel further promoted a reduction in the concentrations of CREB, JNK, NF-kB, p-38, ERK1/2, AKT, P70S6K, and STAT in both cell lines. Mel reverses Warburg-type metabolism and possibly reduces glutaminolysis, thereby attenuating various oncogenic molecules associated with OC progression and invasion.
[Display omitted]
•Melatonin reduces glycolysis and increases pyruvate dehydrogenase activity in OC cells.•Ovarian cancer metabolism-related enzyme activities were altered by melatonin.•Melatonin has a broad impact on reducing key molecules associated with OC progression.•Melatonin reverses Warburg-type metabolism of OC cells in the presence of luzindole.</description><subject>Cellular metabolism</subject><subject>Glutaminolysis</subject><subject>Kinase signaling</subject><subject>Melatonin</subject><subject>Ovarian cancer</subject><subject>Tumor progression</subject><subject>Warburg effect</subject><issn>0303-7207</issn><issn>1872-8057</issn><issn>1872-8057</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kLFu2zAQhokiQe2kfYAugcYsco-kRFLoVARpUyBFl2TKQFDkSaUhkQ4pB_Dbl4bTjJluuO__cfcR8oXChgIVX7eb2eKGAWs2lDLWiQ9kTZVktYJWnpE1cOC1ZCBX5CLnLQDIlqmPZMWVahroxJo8_cbJLDH4UNm_JoyYKwyYxkM142L6OPk8Vya4KqHb27KNwcYRg7dV9mMwkw9jVcLxxSRvSokJFlNlcZryJ3I-mCnj59d5SR5_3D7c3NX3f37-uvl-X1vG26XmxjaqAacYH5zgvRFcUWpt6wCMEj0g9EK2CriT_TAIyXvWSVQCGmmHfuCX5PrUu0vxeY950bPPxwtMwLjPmoNoOwVK8YLSE2pTzDnhoHfJzyYdNAV9dKq3ujjVR6f65LRkrl7r9_2M7i3xX2IBvp0ALE--eEw6W4_Fg_MJ7aJd9O_U_wPm_Ieb</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Silveira, Henrique Spaulonci</creator><creator>Cesário, Roberta Carvalho</creator><creator>Vígaro, Renan Aparecido</creator><creator>Gaiotte, Leticia Barbosa</creator><creator>Cucielo, Maira Smaniotto</creator><creator>Guimarães, Fernando</creator><creator>Seiva, Fábio Rodrigues Ferreira</creator><creator>Zuccari, Debora Aparecida P.C.</creator><creator>Reiter, Russel J.</creator><creator>Chuffa, Luiz Gustavo de Almeida</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7461-8773</orcidid><orcidid>https://orcid.org/0000-0002-0199-3396</orcidid><orcidid>https://orcid.org/0000-0002-5537-972X</orcidid></search><sort><creationdate>20241001</creationdate><title>Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells</title><author>Silveira, Henrique Spaulonci ; Cesário, Roberta Carvalho ; Vígaro, Renan Aparecido ; Gaiotte, Leticia Barbosa ; Cucielo, Maira Smaniotto ; Guimarães, Fernando ; Seiva, Fábio Rodrigues Ferreira ; Zuccari, Debora Aparecida P.C. ; Reiter, Russel J. ; Chuffa, Luiz Gustavo de Almeida</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cellular metabolism</topic><topic>Glutaminolysis</topic><topic>Kinase signaling</topic><topic>Melatonin</topic><topic>Ovarian cancer</topic><topic>Tumor progression</topic><topic>Warburg effect</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silveira, Henrique Spaulonci</creatorcontrib><creatorcontrib>Cesário, Roberta Carvalho</creatorcontrib><creatorcontrib>Vígaro, Renan Aparecido</creatorcontrib><creatorcontrib>Gaiotte, Leticia Barbosa</creatorcontrib><creatorcontrib>Cucielo, Maira Smaniotto</creatorcontrib><creatorcontrib>Guimarães, Fernando</creatorcontrib><creatorcontrib>Seiva, Fábio Rodrigues Ferreira</creatorcontrib><creatorcontrib>Zuccari, Debora Aparecida P.C.</creatorcontrib><creatorcontrib>Reiter, Russel J.</creatorcontrib><creatorcontrib>Chuffa, Luiz Gustavo de Almeida</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silveira, Henrique Spaulonci</au><au>Cesário, Roberta Carvalho</au><au>Vígaro, Renan Aparecido</au><au>Gaiotte, Leticia Barbosa</au><au>Cucielo, Maira Smaniotto</au><au>Guimarães, Fernando</au><au>Seiva, Fábio Rodrigues Ferreira</au><au>Zuccari, Debora Aparecida P.C.</au><au>Reiter, Russel J.</au><au>Chuffa, Luiz Gustavo de Almeida</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells</atitle><jtitle>Molecular and cellular endocrinology</jtitle><addtitle>Mol Cell Endocrinol</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>592</volume><spage>112296</spage><pages>112296-</pages><artnum>112296</artnum><issn>0303-7207</issn><issn>1872-8057</issn><eissn>1872-8057</eissn><abstract>Ovarian cancer (OC) adjusts energy metabolism in favor of its progression and dissemination. Because melatonin (Mel) has antitumor actions, we investigated its impact on energy metabolism and kinase signaling in OC cells (SKOV-3 and CAISMOV-24). Cells were divided into control and Mel-treated groups, in the presence or absence of the antagonist luzindole. There was a decrease in the levels of HIF-1α, G6PDH, GAPDH, PDH, and CS after Mel treatment even in the presence of luzindole in both OC cells. Mel treatment also reduced the activity of OC-related enzymes including PFK-1, G6PDH, LDH, CS, and GS whereas PDH activity was increased. Lactate and glutamine levels dropped after Mel treatment. Mel further promoted a reduction in the concentrations of CREB, JNK, NF-kB, p-38, ERK1/2, AKT, P70S6K, and STAT in both cell lines. Mel reverses Warburg-type metabolism and possibly reduces glutaminolysis, thereby attenuating various oncogenic molecules associated with OC progression and invasion.
[Display omitted]
•Melatonin reduces glycolysis and increases pyruvate dehydrogenase activity in OC cells.•Ovarian cancer metabolism-related enzyme activities were altered by melatonin.•Melatonin has a broad impact on reducing key molecules associated with OC progression.•Melatonin reverses Warburg-type metabolism of OC cells in the presence of luzindole.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38844096</pmid><doi>10.1016/j.mce.2024.112296</doi><orcidid>https://orcid.org/0000-0002-7461-8773</orcidid><orcidid>https://orcid.org/0000-0002-0199-3396</orcidid><orcidid>https://orcid.org/0000-0002-5537-972X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0303-7207 |
ispartof | Molecular and cellular endocrinology, 2024-10, Vol.592, p.112296, Article 112296 |
issn | 0303-7207 1872-8057 1872-8057 |
language | eng |
recordid | cdi_proquest_miscellaneous_3065980883 |
source | ScienceDirect Journals |
subjects | Cellular metabolism Glutaminolysis Kinase signaling Melatonin Ovarian cancer Tumor progression Warburg effect |
title | Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A28%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Melatonin%20changes%20energy%20metabolism%20and%20reduces%20oncogenic%20signaling%20in%20ovarian%20cancer%20cells&rft.jtitle=Molecular%20and%20cellular%20endocrinology&rft.au=Silveira,%20Henrique%20Spaulonci&rft.date=2024-10-01&rft.volume=592&rft.spage=112296&rft.pages=112296-&rft.artnum=112296&rft.issn=0303-7207&rft.eissn=1872-8057&rft_id=info:doi/10.1016/j.mce.2024.112296&rft_dat=%3Cproquest_cross%3E3065980883%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c235t-3ac4840d823fd63ba63811cc5d00a86b0e0b675803d7bff673b297e86047cfbf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3065980883&rft_id=info:pmid/38844096&rfr_iscdi=true |